# Validation of a Method to Search Residual Disease in Auto-cryopreserved Ovarian Tissues

> **NCT02900625** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 240 (estimated)

## Conditions studied

- Neoplastic Pathology
- Minimal Residual Disease
- Cryopreserved Ovarian Tissue

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02900625
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2021-01-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02900625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02900625, "Validation of a Method to Search Residual Disease in Auto-cryopreserved Ovarian Tissues". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02900625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*